Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin...

Published on 8 Nov 2024 on Benzinga · via Yahoo Finance

Consumer health company Kenvue Inc. (NYSE:KVUE) reported third-quarter sales of $3.89 billion, down...

Read the rest of the article

Start tracking your investments with Statfolio

And, most ETFs are very transparent products that... (K) accounts for about 1.65% of total assets...

Zacks · via Yahoo Finance 19 Nov 2024

We recently published a list of 10 Best Predictive Analytics Stocks to Invest in Now. In this...

Insider Monkey · via Yahoo Finance 16 Nov 2024

Crossmark Global Holdings Inc. grew its position in Kenvue Inc. (NYSE:KVUE – Free Report) by 8.1%...

ETF DAILY NEWS 14 Nov 2024

Venturi Wealth Management LLC raised its position in Kenvue Inc. (NYSE:KVUE – Free Report) by 100...

ETF DAILY NEWS 14 Nov 2024

On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active...

Benzinga · via Yahoo Finance 9 Nov 2024

Kenvue Inc., the owner of Tylenol and Neutrogena, reported sales that trailed estimates after its...

The Business of Fashion 8 Nov 2024

We recently published a list of 8 Best Consumer Staples Stocks To Buy Right Now. In this article,...

Insider Monkey · via Yahoo Finance 8 Nov 2024

Consumer health company Kenvue Inc. (NYSE:KVUE) reported third-quarter sales of $3.89 billion, do...

Benzinga · via Yahoo Finance 8 Nov 2024

Kenvue has a formidable lineup of well-known consumer health brands, such as Aveeno, Tylenol,...

GuruFocus.com · via Yahoo Finance 22 Oct 2024

, opens new tab a bargain and said its skin health and beauty segment's lackluster growth is the...

Reuters 22 Oct 2024